These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29881370)

  • 1. Do Patients With Parkinson's Disease Exhibit Reduced Cheating Behavior? A Neuropsychological Study.
    Abe N; Kawasaki I; Hosokawa H; Baba T; Takeda A
    Front Neurol; 2018; 9():378. PubMed ID: 29881370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to anticipated reward in the nucleus accumbens predicts behavior in an independent test of honesty.
    Abe N; Greene JD
    J Neurosci; 2014 Aug; 34(32):10564-72. PubMed ID: 25100590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic honesty forgoing reward acquisition and punishment avoidance: a functional MRI investigation.
    Yoneda M; Ueda R; Ashida H; Abe N
    Neuroreport; 2017 Sep; 28(14):879-883. PubMed ID: 28746066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of neural activity associated with honest and dishonest moral decisions.
    Greene JD; Paxton JM
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12506-11. PubMed ID: 19622733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced engagement of the anterior cingulate cortex in the dishonest decision-making of incarcerated psychopaths.
    Abe N; Greene JD; Kiehl KA
    Soc Cogn Affect Neurosci; 2018 Sep; 13(8):797-807. PubMed ID: 29982639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss.
    Aarts E; Helmich RC; Janssen MJ; Oyen WJ; Bloem BR; Cools R
    Neuroimage; 2012 Feb; 59(4):3339-46. PubMed ID: 22166793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
    Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
    Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human moral decision-making through the lens of Parkinson's disease.
    Ponsi G; Scattolin M; Villa R; Aglioti SM
    NPJ Parkinsons Dis; 2021 Mar; 7(1):18. PubMed ID: 33654110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-Dependent Loss Aversion during Effort-Based Decision-Making.
    Chen X; Voets S; Jenkinson N; Galea JM
    J Neurosci; 2020 Jan; 40(3):661-670. PubMed ID: 31727795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-related personality traits in Parkinson's disease.
    Menza MA; Golbe LI; Cody RA; Forman NE
    Neurology; 1993 Mar; 43(3 Pt 1):505-8. PubMed ID: 8450991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigrostriatal and Mesolimbic D
    Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
    J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond monetary value: how reward type drives cheating in a gender-judgment task.
    Chen GZ; Zhao FF; Li HM; Wu YW; Yan WJ
    Front Psychol; 2024; 15():1290793. PubMed ID: 38836237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of dopamine and cognitive impairment on neural reactivity to facial emotion in Parkinson's disease.
    Dan R; Růžička F; Bezdicek O; Roth J; Růžička E; Vymazal J; Goelman G; Jech R
    Eur Neuropsychopharmacol; 2019 Nov; 29(11):1258-1272. PubMed ID: 31607424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired learning of punishments in Parkinson's disease with and without impulse control disorder.
    Leplow B; Sepke M; Schönfeld R; Pohl J; Oelsner H; Latzko L; Ebersbach G
    J Neural Transm (Vienna); 2017 Feb; 124(2):217-225. PubMed ID: 27848033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How attentional boost interacts with reward: the effect of dopaminergic medications in Parkinson's disease.
    Kéri S; Nagy H; Levy-Gigi E; Kelemen O
    Eur J Neurosci; 2013 Dec; 38(11):3650-8. PubMed ID: 24011183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality Traits and Cortical Activity Affect Gambling Behavior in Parkinson's Disease.
    Balconi M; Siri C; Meucci N; Pezzoli G; Angioletti L
    J Parkinsons Dis; 2018; 8(2):341-352. PubMed ID: 29614700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered EEG alpha and theta oscillations characterize apathy in Parkinson's disease during incentivized movement.
    Zhu M; HajiHosseini A; Baumeister TR; Garg S; Appel-Cresswell S; McKeown MJ
    Neuroimage Clin; 2019; 23():101922. PubMed ID: 31284232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.